Metkefamide (original) (raw)
Metkefamide (INN; LY-127,623), or metkephamid acetate (USAN), but most frequently referred to simply as metkephamid, is a synthetic opioid pentapeptide and derivative of [Met]enkephalin with the amino acid sequence Tyr-D-Ala-Gly-Phe-(N-Me)-Met-NH2. It behaves as a potent agonist of the δ- and μ-opioid receptors with roughly equipotent affinity, and also has similarly high affinity as well as subtype-selectivity for the κ3-opioid receptor.
Property | Value |
---|---|
dbo:abstract | Metkefamide (INN; LY-127,623), or metkephamid acetate (USAN), but most frequently referred to simply as metkephamid, is a synthetic opioid pentapeptide and derivative of [Met]enkephalin with the amino acid sequence Tyr-D-Ala-Gly-Phe-(N-Me)-Met-NH2. It behaves as a potent agonist of the δ- and μ-opioid receptors with roughly equipotent affinity, and also has similarly high affinity as well as subtype-selectivity for the κ3-opioid receptor. Despite its peptidic nature, upon systemic administration, metkefamide rapidly penetrates the blood-brain-barrier and disperses into the central nervous system where it produces potent, centrally-mediated analgesic effects, of which have been shown to be dependent on activity at both the μ- and δ-opioid receptors. In addition, on account of modifications to the N- and C-terminals, metkefamide is highly stable against proteolytic degradation relative to many other opioid peptides. As an example, while its parent peptide, [Met]enkephalin, has an in vivo half-life of merely seconds, metkefamide has a half-life of nearly 60 minutes, and upon intramuscular administration, has been shown to provide pain relief that lasts for hours. Likely on account of its δ-opioid activity, clinical trials have found metkefamide to possess less of a tendency for producing many of the undesirable side effects usually associated with conventional opioids such as respiratory depression, tolerance, and physical dependence. However, it has been shown to cause some additional side effects that are considered unusual for standard opioid analgesics like sensations of heaviness in the extremities and nasal congestion—though these were not considered to be particularly distressing—and it has also been shown to raise the seizure threshold in animals. In any case, clinical development was not further pursued after phase I clinical studies and metkefamide never reached the pharmaceutical market. (en) |
dbo:bioavailability | 30.000000 (xsd:float) |
dbo:casNumber | 66960-34-7 66960-35-8 (acetate) |
dbo:fdaUniiCode | MNL20FXH9Y |
dbo:pubchem | 5464184 |
dbo:thumbnail | wiki-commons:Special:FilePath/Metkefamide.svg?width=300 |
dbo:wikiPageID | 35641157 (xsd:integer) |
dbo:wikiPageLength | 9666 (xsd:nonNegativeInteger) |
dbo:wikiPageRevisionID | 1049067767 (xsd:integer) |
dbo:wikiPageWikiLink | dbr:Potency_(pharmacology) dbr:Peptide dbr:Δ-opioid_receptor dbc:Analgesics dbr:Organic_compound dbr:Proteolysis dbr:Opioid_peptide dbr:Clinical_trial dbr:Systemic_administration dbr:Physical_dependence dbr:Drug_tolerance dbr:Acetate dbr:Agonist dbr:Analgesic dbr:Pain_relief dbr:Central_nervous_system dbr:Frakefamide dbr:Nasal_congestion dbr:Half-life dbr:Hepatic dbr:International_Nonproprietary_Name dbr:Μ-opioid_receptor dbc:Opioid_peptides dbr:Affinity_(pharmacology) dbr:Seizure_threshold dbr:C-terminus dbr:Met-enkephalin dbr:Side_effect dbr:United_States_Adopted_Name dbr:Phases_of_clinical_research dbr:N-terminus dbr:Intramuscular_administration dbr:Amino_acid_sequence dbr:Blood-brain-barrier dbr:Respiratory_depression dbr:Kappa-opioid_receptor dbr:Sensations_of_heaviness_in_the_extremities |
dbp:atcPrefix | None (en) |
dbp:bioavailability | 30 (xsd:integer) |
dbp:c | 29 (xsd:integer) |
dbp:casNumber | 66960 (xsd:integer) |
dbp:casSupplemental | 66960 (xsd:integer) |
dbp:chemspiderid | 4576570 (xsd:integer) |
dbp:eliminationHalfLife | 3600.0 |
dbp:h | 40 (xsd:integer) |
dbp:iupacName | (L)-tyrosyl-(D)-alanylglycyl-(L)-phenylalanyl-N2-methyl-(L)-methioninamide (en) |
dbp:metabolism | dbr:Hepatic |
dbp:n | 6 (xsd:integer) |
dbp:o | 6 (xsd:integer) |
dbp:proteinBound | 44 (xsd:integer) |
dbp:pubchem | 5464184 (xsd:integer) |
dbp:s | 1 (xsd:integer) |
dbp:smiles | O=C[C@@H]CCSC (en) |
dbp:stdinchi | 1 (xsd:integer) |
dbp:stdinchikey | FWDIKROEWJOQIQ-JMBSJVKXSA-N (en) |
dbp:unii | MNL20FXH9Y (en) |
dbp:wikiPageUsesTemplate | dbt:Drugbox dbt:Opioidergics dbt:Reflist dbt:Fdacite |
dcterms:subject | dbc:Analgesics dbc:Opioid_peptides |
gold:hypernym | dbr:Pentapeptide |
rdf:type | owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q8386 yago:WikicatAmides yago:WikicatOpioidPeptides yago:Abstraction100002137 yago:Amide114724264 yago:Chemical114806838 yago:Compound114818238 yago:Material114580897 yago:Matter100020827 yago:OrganicCompound114727670 yago:Part113809207 yago:Peptide114743046 yago:PhysicalEntity100001930 yago:Relation100031921 dbo:Drug yago:Substance100019613 |
rdfs:comment | Metkefamide (INN; LY-127,623), or metkephamid acetate (USAN), but most frequently referred to simply as metkephamid, is a synthetic opioid pentapeptide and derivative of [Met]enkephalin with the amino acid sequence Tyr-D-Ala-Gly-Phe-(N-Me)-Met-NH2. It behaves as a potent agonist of the δ- and μ-opioid receptors with roughly equipotent affinity, and also has similarly high affinity as well as subtype-selectivity for the κ3-opioid receptor. (en) |
rdfs:label | Metkefamide (en) |
owl:sameAs | freebase:Metkefamide yago-res:Metkefamide wikidata:Metkefamide dbpedia-sh:Metkefamide dbpedia-sr:Metkefamide https://global.dbpedia.org/id/4s8te |
prov:wasDerivedFrom | wikipedia-en:Metkefamide?oldid=1049067767&ns=0 |
foaf:depiction | wiki-commons:Special:FilePath/Metkefamide.svg |
foaf:isPrimaryTopicOf | wikipedia-en:Metkefamide |
is dbo:wikiPageRedirects of | dbr:Metkefamid dbr:Metkefamid_acetate dbr:Metkefamide_acetate dbr:Metkephamid dbr:Metkephamid_acetate dbr:Metkephamide dbr:Metkephamide_acetate dbr:LY-127,623 dbr:LY-127623 dbr:LY_127623 |
is dbo:wikiPageWikiLink of | dbr:List_of_opioids dbr:Frakefamide dbr:Metkefamid dbr:Metkefamid_acetate dbr:Metkefamide_acetate dbr:Metkephamid dbr:Metkephamid_acetate dbr:Metkephamide dbr:Metkephamide_acetate dbr:List_of_drugs:_Met dbr:LY-127,623 dbr:LY-127623 dbr:LY_127623 |
is foaf:primaryTopic of | wikipedia-en:Metkefamide |